Logo
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-NVAX-Novavax Inc

Novavax Inc NVAX

6.670.25(3.89%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Novavax Inc
Today
Create an eToro account to buy NVAX stock on a secure, user-friendly, multi-asset trading platform.
Buy Novavax Inc
Buy Novavax Inc
Novavax Inc NVAX
Buy NVAX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
9
Based on analysts who covered NVAX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Novavax Inc News

NVAX Stock Price Chart

‎2.94‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Novavax Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Novavax Inc share price today is 6.67, reflecting a ‎3.89‎% change over the last 24 hours and ‎-11.1‎% over the past week. The current market capitalization of NVAX is 1.03B with an average volume in the last three months of 5.16M. The stock has a P/E ratio of -4.85 and a dividend yield of 0%. With the stock’s beta sitting at 1.83
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
1.03B
Day’s Range
i
Shows the high and low prices of the day.
5.5 - 7.79
52W Range
i
Shows the high and low prices of the last year.
3.52 - 23.37
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
5.16M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-4.85
Revenue
i
The total income generated by this company’s goods and services last year.
682.16M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
6.42
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.32
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.83
What Is Novavax Inc?
Novavax Inc is an American biotechnology company based in Gaithersburg, Maryland. The firm is engaged in the development of vaccines that address some of the world’s most serious and hard-to-treat infectious diseases, including COVID-19, RSV, Ebola, MERS, SARS, and seasonal influenza. The firm has a number of products at various stages in its pipeline, aimed at the prevention of a wide range of diseases. As of November 2021, the firm’s VX-CoV2373 coronavirus candidate is in advanced clinical trials. Novavax Inc was founded in 1987 and operates globally.

The company is engaged in the development of proprietary immune-stimulating adjuvants, which are being developed at Novavax AB, the firm’s wholly owned subsidiary in Sweden. The company’s primary immune-stimulating adjuvant for use in humans is Matrix-M™.

In 2020, the firm won a $1.6bn award from the US government to produce a vaccine for COVID-19 as part of the Operation Warp Speed initiative. The Coalition for Epidemic Preparedness Innovations (CEPI) has also committed to invest $388m in the development of the company’s coronavirus vaccine. The firm is listed on the NASDAQ, where it trades under the ticker NVAX.

Start monitoring the NVAX price chart for value changes by adding this stock to your eToro watchlist today.
Buy NVAX

How can I buy Novavax Inc stocks?

To purchase Novavax Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Novavax Inc (NVAX) page and place an order to buy Novavax Inc.
Buy NVAX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Novavax Inc
Invest in Novavax Inc
Today
Create an eToro account to buy NVAX stock on a secure, user-friendly, multi-asset trading platform.
Buy NVAX

FAQ

The current price of NVAX is 6.67.
The average price target for Novavax Inc is 6.67. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Novavax Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Novavax Inc is 1.03B
Based on 1 analysts offering recommendations for NVAX in the last 3 months, the overall consensus is Hold.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top